Home › Research › Risk genes beyond APOE
Cuando el Alzheimer llega antes de lo esperado: la mutación del gen PSEN1
Jesús Alberto Gutiérrez Brito, Diego Edgardo Casillas Arroyo, Jorge Hernández Bello. Con Evidencia, 2025-01-01
Topic: Amyloid, tau and blood-test diagnosis
Plain-language summary
Studies in Jalisco have identified a mutation in the PSEN1 gene, associated with early-onset Alzheimer's. This variant, common in the Altos de Jalisco region, affects both men and women, causing severe symptoms such as difficulty walking and speaking. Symptoms appear much earlier than usual, with faster progression and a shorter life expectancy. Migration has spread the variant to other regions, raising concerns. It is crucial to continue investigating its clinical impact and to develop counseling programs for the affected population.
What this study adds
Evidence grade: Low
This article describes a PSEN1 gene mutation found in the Altos de Jalisco region of Mexico that is associated with early-onset Alzheimer's, causing severe symptoms, faster progression and shorter life expectancy, and has spread through migration. It calls for continued research into its clinical impact and for counseling programs, but reports no treatment or cure.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Brito, J. A. G., Arroyo, D. E. C., & Bello, J. H. (2025). Cuando el Alzheimer llega antes de lo esperado: la mutación del gen PSEN1. Con Evidencia. https://doi.org/10.32870/ce.vi5.138
Vancouver
Brito JAG, Arroyo DEC, Bello JH. Cuando el Alzheimer llega antes de lo esperado: la mutación del gen PSEN1. Con Evidencia. 2025. doi:10.32870/ce.vi5.138.
BibTeX
@article{brito2025-752aedc0,
author = {Brito, Jesús Alberto Gutiérrez and Arroyo, Diego Edgardo Casillas and Bello, Jorge Hernández},
title = {{Cuando el Alzheimer llega antes de lo esperado: la mutación del gen PSEN1}},
journal = {Con Evidencia},
year = {2025},
doi = {10.32870/ce.vi5.138},
url = {https://doi.org/10.32870/ce.vi5.138}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. Check the citation against the original before you use it.
Key findings
- Studies in Jalisco have identified a mutation in the PSEN1 gene, associated with early-onset Alzheimer's.
Why it matters
This article describes a PSEN1 gene mutation found in the Altos de Jalisco region of Mexico that is associated with early-onset Alzheimer's, causing severe symptoms, faster progression and shorter life expectancy, and has spread through migration. It calls for continued research into its clinical impact and for counseling programs, but reports no treatment or cure.
New to this subject? Start with our plain-English guide: Genetics →
Study details
- Evidence strengthLow
How this study scored 26/100
Published in a peer-reviewed journal. Scored zero for study design, sample size, effect reported, studied in people and randomized / blinded because the record does not state it. We have no data on senior author's track record, so that was left out: it earned 25 of the 96 points we could judge it on, which is 26 out of 100.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (Con Evidencia) |
| Journal's citation record | 0 / 4 | Con Evidencia: journal h-index 1 (OpenAlex, 2026-10-29) |
| Study design | 0 / 12 | No study design recorded — scores zero, not guessed (not stated in the record — scored 0) |
| Strength of evidence | 1 / 5 | Rated “low” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 4 / 5 | 2025 — within 3 year(s) of the newest study here |
| Sample size | 0 / 4 | Participant count not stated — scores zero (not stated in the record — scored 0) |
| Effect reported | 0 / 3 | No effect size reported — scores zero (not stated in the record — scored 0) |
| Studied in people | 0 / 3 | Not stated whether this was studied in people — scores zero (not stated in the record — scored 0) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 0 / 7 | Cited 0 times (OpenAlex, 2026-10-10) |
| Citations per year | 0 / 5 | 0.0 citations a year over 3 year(s) since 2025 |
| Impact for its field and year | 0 / 6 | Cited 0.0× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 0 / 6 | No other study in this library cites it |
| Still being cited | 0 / 4 | Cited 0 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | — / 4 | Senior author's record not available — left out of this score |
| Institution's track record | 0 / 3 | Universidad de Guadalajara: institution h-index 230 (OpenAlex) |
| Multicenter collaboration | 0 / 3 | OpenAlex lists 1 institution(s) in 1 country — scores zero (affiliation lists can be incomplete) |
| Indexed in PubMed | 1 / 2 | Not in PubMed, but has a DOI |
| Free to read | 2 / 2 | Free to read |
| Points | 25 / 96 | Scored on 19 of 20 parts. We have no data for the rest, so they are left out: 25 of the 96 points we could judge it on is 26 out of 100. |
| Total | 26 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).
Related
Studies in the library that share something with this one. The line above each title says what.
Related studies in Risk genes beyond APOE from nearby years
Also in Risk genes beyond APOE
103 studies in the library are filed under Risk genes beyond APOE with no topic tag they share with another; these are this study's neighbours in a fixed tour of them. The Risk genes beyond APOE hub.